Clinical trials in head injury

Neurological Research

Volumn 21, Issue 4, 1999, Pages 330-338

  Reinert, Michael M ^a   Bullock, Ross ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Head injury; Neuroprotection; Pathomechanism; Secondary injury; Therapy; Trials

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; APTIGANEL; ARACHIDONIC ACID; BARBITURIC ACID DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; CALMODULIN; CALPAIN; DEXAMETHASONE; DIACYLGLYCEROL; DIHYDROPYRIDINE; DIZOCILPINE; ELIPRODIL; GUANYLATE CYCLASE; INDOMETACIN; INOSITOL TRISPHOSPHATE; KAINIC ACID; MANNITOL; METHYLPREDNISOLONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPROTECTIVE AGENT; NIMODIPINE; PHOSPHOLIPASE A2; POTASSIUM CHANNEL BLOCKING AGENT; PROPOFOL; PROSTAGLANDIN; PROTEIN KINASE C; SCAVENGER; STEROID; SUPEROXIDE DISMUTASE MACROGOL; THROMBOXANE;

ARTICLE; BRAIN INJURY; CLINICAL TRIAL; DOSE RESPONSE; DRUG MECHANISM; HEAD INJURY; HUMAN; HYPERTENSION; HYPOTHERMIA; INTRACRANIAL HYPERTENSION; NEUROPROTECTION;

EID: 0033035420     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1080/01616412.1999.11740940     Document Type: Article

References (77)

1. Doppenberg EM, Bullock R. Clinical neuro-protection trials in severe traumatic brain injury: Lessons from previous studies. J Neurotrauma 1997; 14: 71-80
2. Jenkins LW, Moszynski K, Lyeth BG, et al. Increased vulnerability of the mildly traumatized rat brain to cerebral ischemia: The use of controlled secondary ischemia as a research tool to identify common or different mechanisms contributing to mechanical and ischemic brain injury. Brain Res 1989; 477: 211-224
3. Lewelt W, Jenkins LW, Miller JD. Autoregulation of cerebral blood flow after experimental fluid percussion injury of the brain. J Neurosurg 1980; 53: 500-511
4. Katayama Y, Becker D, Tamura T, Hovda D. Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury. J Neurosurg 1990; 73: 889-900
5. McClellan D, et al. The structural basis of the vegetative state and prolonged coma after non-missile injury. In: Le Coma Traumatique, Padova: I. Papo, F. Cohadon, M. Massarotti, 1986: pp. 165-185
6. Povlishock JT, Becker DP, Cheng CL, Vaughan GW. Axonal change in minor head injury. J Neuropathol Exp Neurol 1983; 42: 225-242
7. Pettus EH, Christman CW, Giebel ML, Povlishock JT. Traumatically induced altered membrane permeability: Its relationship to traumatically induced reactive axonal change. J Neurotrauma 1994; 11: 507-522
8. Okonkwo D, Povlishock J. Cyclosporin A limits mitochondrial damage and attenuates axonal disruption but does not accelerate motor recovery in traumatic brain injury. J Neurotrauma 1998; 15: 889
9. Graham DI. The pathology of brain ischaemia and possibilities for therapeutic intervention. Br J Anaesth 1985; 57: 3-17
10. Adams JH, Graham, DI, Gennarelli TA. Head injury in man and experimental animals: Neuropathology. Acta Neurochir Suppl (Wien) 1983; 32: 15-30
11. Bouma GJ, Muizelaar JP, Stringer WA, Choi SC, Fatouros P, Young HF. Ultra-early evaluation of regional cerebral blood flow in severely head-injured patients using xenon-enhanced computerized tomography [see comments]. J Neurosurg 1992; 77: 360-368
12. Schroder ML, Muizelaar JP, Bullock MR, Salvant JB, Povlishock JT. Focal ischemia due to traumatic contusions documented by stable xenon-CT and ultrastructural studies. J Neurosurg 1995; 82: 966-971
13. Symon L, Pasztor E, Branston N. The distribution and density of reduced cerebral blood flow following acute middle cerebral artery occlusion: An experimental study by the technique of hydrogen clearance in baboons. Stroke 1974; 5: 355-364
14. Siesjo B. Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology. J Neurosurg 1992; 77: 169-184
15. Siesjo B. Pathophysiology and treatment of focal cerebral ischemia. Part II: Mechanisms of damage and treatment. J Neurosurg 1992; 77: 337-354
16. Jones T, Morawetz R, Crowell R. Threshold of focal cerebral ischemia in awake monkeys. J Neurosurg 1981; 54: 773-782
17. Yoshino A, Hovda D, Kawamata T. Dynamic changes in local cerebral glucose utilization following cerebral concussion in rats: Evidence of a hyper and a subsequent hypometabolic state. Brain Res 1991; 561: 106-119
18. Santos A, Shu E. Extradural hematoma in children: Analysis of 74 cases. J Neurotrauma 1995; 12: 389
19. Bullock R, Zauner A, Woodward J, et al. Factors affecting excitatory amino acid release following severe human head injury. J Neurosurg 1998; 89: 507-518
20. Mendelow A, Bullock R. Intracranial hemorrhage induced at arterial pressure in the rat: Part 2. Short term changes in local cerebral blood flow measured by autoradiography. Neurol Res 1984; 6: 189
21. Lazorthes G, Campan L. Moderate hypothermia in the treatment of head injuries. Clin Neurosurg 1964; 12: 293-299
22. Dietrich WD, Alonso O, Busto R, Globus MY, Ginsberg MD. Post-traumatic brain hypothermia reduces histopathological damage following concussive brain injury in the rat. Acta Neuropathol Berl 1994; 87: 250-258
23. Mansfield RT, Schiding JK, Hamilton RL, Kochanek PM. Effects of hypothermia on traumatic brain injury in immature rats. J Cereb Blood Flow Metab 1996; 16: 244-252
24. Barmlett H, Dietrich W, Green E, Busto R. Chronic histopathological consequences of fluid percussion injury in rats: Effects of post-traumatic hypothermia. Acta Neuropath 1997; 93: 190-199
25. Marion DW, Penrod LE, Kelsey SF, et al. Treatment of traumatic brain injury with moderate hypothermia. N Engl J Med 1997; 336: 540-546
26. Schwartz ML, Tator CH, Rowed DW, Reid SR, Meguro K, Andrews DF. The University of Toronto head injury treatment study: A prospective, randomized comparison of pentobarbital and mannitol. Can J Neurol Sci 1984; 11: 434-440
27. Ward JD, Becker DP, Miller JD, et al. Failure of prophylactic barbiturate coma in the treatment of severe head injury. J Neurosurg 1985; 62: 383-388
28. Saul TG, Ducker TB, Salcman M, Carro E. Steroids in severe head injury: A prospective randomized clinical trial. J Neurosurg 1981; 54: 596-600
29. Faupel G, Reulen H, Muller D. Double blind study on the effects of steroids on severe closed head injury. In: Dynamics of Brain Edema, Berlin: Springer-Verlag, 1976: pp. 337-434
30. Cooper PR, Moody S, Clark WK, et al. Dexamethasone and severe head injury. A prospective double-blind study. J Neurosurg 1979; 51: 307-316
31. Dearden NM, Gibson JS, McDowall DG, Gibson RM, Cameron MM. Effect of high-dose dexamethasone on outcome from severe head injury. J Neurosurg 1986; 64: 81-88
32. Giannotta SL, Weiss MH, Apuzzo ML, Martin E. High dose glucocorticoids in the management of severe head injury. Neurosurgery 1984; 15: 497-501
33. Gaab MR, Trost HA, Alcantara A, et al. 'Ultrahigh' dexamethasone in acute brain injury. Results from a prospective randomized double-blind multicenter trial (GUDHIS). German Ultrahigh Dexamethasone Head Injury Study Group. Zentralbl Neurochir 1994; 55: 135-143
34. Grumme T, Baethmann A, Kolodziejczyk D, et al. Treatment of patients with severe head injury by triamcinilone: A prospective, controlled multicenter clinical trial of 396 cases. Res Exp Med Berl 1995; 195: 217-229
35. Bracken M. Administration of methylprednisolone for 24 or 48 hours or Tirizalad mesylate for 48 h in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 1997; 28: 1597-1604
36. Kontos HA, Povlishock JT. Oxygen radicals in brain injury. Cent Nerv Syst Trauma 1986; 3: 257-263
37. Muizelaar JP. Cerebral ischemia-reperfusion injury after severe head injury and its possible treatment with polyethyleneglycolsuperoxide dismutase. Ann Emerg Med 1993; 22: 1014-1021
38. Hall E. Free radicals and CNS injury. Crit Care Clin 1989; 5: 793-805
39. Althaus JS, Andrus PK, Williams CM, VonVoigtlander PF, Cazers AR, Hall ED. The use of salicylate hydroxylation to detect hydroxyl radical generation in ischemic and traumatic brain injury. Reversal by tirilazad mesylate (U-74006F). Mol Chem Neuropath 1993; 20: 147-162
40. Flamm ES, Demopoulos HB, Seligman ML, Poser RG, Ransohoff J. Free radicals in cerebral ischemia. Stroke 1978; 9: 445-447
41. Dhillon H, Carbary T. Activation of phosphatidylinositol bisphosphate signal transduction pathway after experimental brain injury: A lipid study. Brain Res 1995; 698: 100-106
42. Frandsen A, Schousboe A. Excitatory amino acid mediated cytocoxicity and calcium homeostasis in cultured neurons. J Neurochem 1993; 60: 1202-1211
43. Biestro AA, Alberti RA, Soca AE, Cancela M, Puppo CB, Borovich B. Use of indomethacin in brain-injured patients with cerebral perfusion pressure impairment: Preliminary report. J Neurosurg 1995; 83: 627-630
44. Jensen K, Ohrstrom J, Cold GE, Astrup J. The effects of indomethacin on intracranial pressure, cerebral blood flow and cerebral metabolism in patients with severe head injury and intracranial hypertension. Acta Neurochir Wien 1991; 108: 116-121
45. Cold GE, Jensen K, Astrup J, Ohrstrom J. Indomethacin in severe head injury [letter]. Neurosurgery 1990; 27: 660-661
46. Choi DW. Calcium-mediated neurotoxicity: Relationship to specific channel types and role in ischemic damage. Trends Neurosci 1988; 11: 465-469
47. Siesjo BK. Historical overview. Calcium, ischemia, and death of brain cells. Ann NY Acad Sci 1988; 522: 638-661
48. Kim Lee MH, Stokes BT, Anderson DK. Intracellular calcium dynamics and cerebral injury: Modeling various insults in vitro. Brain Res 1993; 613: 156-159
49. 2- dependent processes as mediators of neurotoxicity. Neurotoxicology 1992; 13: 139
50. Carbone E, Lux H. A low voltage activated fully inactivating calcium channel in vertebrate sensory neurons. Nature 1984; 310: 440
51. Nowycky M, Fox A, Tsien R. Three types of neuronal calcium channels with different calcium agonist sensitivity. Nature 1985; 316: 440
52. Kazda S, Garthoff B, Krause H, Schlossmann K. Cerebrovascular effects of the calcium antagonistic dihydropyridine derivate, nimodipine, in animal experiments. Arzneimittelforschung 1982; 32: 331
53. Towart R. The selective inhibition of serotonin-induced contractions of rabbit cerebrovascular smooth muscle by calcium antagonistic dihydropyridines. An investigation of the mechanism of action of nimodipine. Circ Res 1981; 48: 650
54. Baer P, Renkema G, Veraart C, Hol E, Gispen W. Nimodipine protects cultured spinal cord neurons from depolarization-induced inhibition of neurite outgrowth. Cell 1993; 14: 293
55. Germano I, Bartowski H, Cassel M, Pitts L. The therapeutic value of nimodipine in experimental focal cerebral ischemia. Neurological outcome and histopathological findings. J Neurosurg 1987; 67: 81
56. Mohamed A, Gotoh O, Graham D. Effect of pretreatment with the calcium antagonist nimodipine on local cerebral blood flow and histopathology after middle cerebral artery occlusion. Ann Neurol 1985; 18: 705
57. Jacewicz M, Brint S, Tanabe J, Pulsinelli W. Continuous nimodipine treatment attenuates cortical infarction in rats subjected to 24 hours of focal ischemia. J Cereb Blood Flow Metab 1990; 10: 89
58. Pickard JD, Murray GD, Illingworth R, et al. Effects of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. Br Med J 1989; 298: 636-642
59. Robinson M, Teasdale G. Calcium antagonists in the management of subarachnoid hemorrhage. Cerebrovasc Brain Metab Rev 1990; 2: 205-224
60. Harders A, Kakarieka A, Braakman R. Traumatic subarachnoid hemorrhage and its treatment with nimodipine. German tSAH Study Group. J Neurosurg 1996; 85: 82-89
61. Bullock R, Butcher SP, Chen MH, Kendall L, McCulloch J. Correlation of the extracellular glutamate concentration with extent of blood flow reduction after subdural hematoma in the rat. J Neurosurg 1991; 74: 794-802
62. Bullock R, Fujisawa H, Landolt H. Glutamate induced neurotoxicity and acute brain swelling. In: Kempski O, ed. Glutamate: Transmitter and Toxin, Muenchen: Klinische Ernaehrung, 1993: pp. 113-123
63. Fagg G, Baud J. Characterization of NMDA receptor-ionophore complexes in the brain. In: Lodge D, ed. Excitatory Amino Acids in Health and Disease, Chichester: John Wiley and Sons, 1988: pp. 63-91
64. Kandel ER, Schwartz JH. Directly gated transmission at central synapses. In: Kandel ER, Schwartz JH, Jessell TM, eds. Principles of Neural Science, 3rd edn, New York: Elsevier, 1991: pp. 153-172
65. Johnson J, Asher P. The NMDA receptor and its channel. Modulation by magnesium and by glycine. In: Lodge D, ed. Excitatory Amino Acids in Health and Disease, Chichester: John Wiley and Sons, 1988: 109-121
66. Pulsinelli W. Pathophysiology of acute ischaemic stroke. Lancet 1992; 339: 533-536
67. Greenamyre JT, Porter RH. Anatomy and physiology of glutamate in the CNS. Neurology 1994; 44 (11 Suppl 8): S7-S13
68. Muir KW, Grosset DG, Lees KR. Effects of prolonged infusions of the NMDA antagonist aptiganel hydrochloride (CNS 1102) in normal volunteers. Clin Neuropharmacol 1997; 20: 311-321
69. Olney J, Labruyere J, Price M. Pathological changes induced in cerebrocortical neurons by phencyclidones and related drugs. Science 1989; 244: 1360-1362
70. Stewart L, Bullock R, Teasdale G, Wagstaff A. First observations of safety and tolerability of a competitive antagonist to the glutamate NMDA receptor (CGS 19755) in severely head injured patients. 1996; Unpublished data
71. Albers GW, Atkinson RP, Kelley RE Rosenbaum DM, Safety, tolerability, and pharmacokinetics of the N-methyl-D-aspartate antagonist dextrorphan in patients with acute stroke. Dextrorphan Study Group. Stroke 1995; 26: 254-258
72. Fisher M. Cerestat (CNS 1102), a non-competitive NMDA antagonist in ischemic stroke patients: Dose escalating safety study. Cerebrovasc Dis 1994; 4: 245
73. Nilsson P, Hillered L, Olsson Y, Sheardown M, Hanson A. Regional changes in interstitial potassium and calcium levels following cortical compression, contusion, trauma in rats. J Cereb Blood Flow Metab 1993; 13: 183-192
74. Andine P, Jacobson I, Hagberg H. Enhanced calcium uptake by CA1 pyramidal cell dendrites in the post-ischemic phase despite subnormal evoked field potentials: Excitatory amino acid receptor dependency and relationship to neuronal damage. J Cereb Blood Flow Metab 1992; 12: 773-783
75. Gill R, Andine P, Hillered L, Persson L, Hagberg H. The effect of MK-801 on cortical spreading depression in the penumbral zone following focal ischaemia in the rat. J Cereb Blood Flow Metab 1992; 12: 371-379
76. Nozaki K, Beal MF. Neuroprotective effects of L-kynurenine on hypoxia-ischemia and NMDA lesions in neonatal rats. J Cereb Blood Flow Metab 1992; 12: 400-407
77. Bullock R, Maxwell WL, Graham DI, et al. Glial swelling following human cerebral contusion: An ultrastructural study. J Neurol Neurosurg Psychiatry, 1991; 54: 427-434